IMMUNOBIOLOGY OF DIPHTHERIA. RECENT APPROACHES FOR THE PREVENTION, DIAGNOSIS, AND TREATMENT OF DISEASE
Journal: Biotechnologia Acta (Vol.6, No. 4)Publication Date: 2013-08-30
Authors : D. V. Kolybo; A. A. Labyntsev; S. I. Romaniuk; A. A Kaberniuk; O. M. Oliinyk; N. V. Korotkevich; S. V. Komisarenko;
Page : 43-62
Keywords : diphtheria; diphtheria toxin; immunity; diagnostic tests; vaccines; antidotes; recombinant proteins.;
Abstract
Diphtheria is a highly contagious life-threatening disease caused by the toxi genic strains of Corynebacterium diphtheria, which are transformed by a bacteriophage carrying the toxin gene. Diphtheria causative agent and its major virulence factor diphtheria toxin are well studied, but outbreaks of disease still occur worldwide. Rapid development of new methods in immunology and molecular biology is currently leading to improvement of prophylaxis, diagnosis and treatment of diphtheria. This review highlights the microbiological, epidemiological and immunological aspects of diphtheria infection, role of diphtheria toxin and others virulence factors in diphtheria pathogenesis and role of humoral anti-toxic immunity in the protection against disease. Perspectives in development of new diagnostic tests, anti-diphtheria vaccines, immunobiological preparations and antidotes for prevention of diphtheria infection, and other anti-diphteria means was also discussed.
Other Latest Articles
- SOME RECENT FINDINGS IN THE BIOTECHNOLOGY OF BIOLOGICALLY IMPORTANT NUCLEOSIDES
- SEARCH OF INHIBITORS OF HERPES VIRAL REPLICATION: 30 YEARS AFTER ACYCLOVIR
- RECOMBINANT HORSERADISH PEROXIDASE FOR ANALYTICAL APPLICATIONS
- MODERN TECHNIQUES OF IMMUNOCHEMICAL ANALYSIS: INTEGRATION OF SENSITIVITY AND RAPIDITY
- INDIVIDUALIZATION OF CANCER TREATMENT: CONTRIBUTION OF OMICS TECHNOLOGIES TO CANCER DIAGNOSTIC
Last modified: 2016-11-19 01:46:52